Study Detail

Neonatal complications of coronavirus disease (COVID-19)

Neonatal Complications of Coronavirus Disease (COVID-19) Study

Status: Open

Type: Observational

Funder: NIHR

Sponsor: University of Oxford

CI: Dr Jenny Kurinczuk

IRAS-Number: 282127

CPMS-ID: 45676

Approval Date: 21 April 2020

Description:

Coronavirus is a new virus that has come from China where it was first recognised as a causing a new infection (COVID-19) in late 2019. So far we have very little information about how the virus affects mothers and newborn babies and it is not clear how best to care for mothers and babies affected. We have very little information about how babies get Coronavirus infection, whether it transmits from mothers to their baby(s) while they are still pregnant, during labour and birth, or whether the infection occurs following birth. Understanding this will mean that we can give the best care to mothers and babies and the best advice to pregnant women about the effects of Coronavirus on their baby. This study will collect information about newborn babies who have Coronavirus or who are born to mothers who have Coronavirus. Thw information we collect will help us to understand: • How babies get Coronavirus • What happens to babies when their mother has Coronavirus • What treatments are effective in helping babies with Coronavirus to get better • What happens to babies when they have been treated We are carrying out the study through a system called the British Paediatric Surveillance Unit (BPSU) www.rcpch.ac.uk/work-we-do/bpsu. Each week every doctor across the UK looking after newborn babies in hospital will be asked by the BPSU if they have looked after a newborn baby with Coronavirus or whose mother has Coronavirus. If they have, they will be sent a questionnaire to collect information about the baby and their mother. As this information is needed very urgently about all affected babies we will not be asking parents for consent to include their baby's information in the study, although parents will be able to opt out.

Back to listing